BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products
June 26, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two...
BioSyent Schedules Q4 2018 Earnings Release for March 20, 2019
March 15, 2019 12:35 ET
|
BioSyent Inc.
TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended December 31, 2018...
BioSyent Schedules Q3 2018 Earnings Release for November 21, 2018
November 08, 2018 09:22 ET
|
BioSyent Inc.
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2018...
BioSyent Releases Q2 and H1 2018 Results
August 22, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2018. Key...